Skip to main navigation Skip to search Skip to main content

Clinical implications of high MET gene dosage in non-small cell lung cancer patients without previous tyrosine kinase inhibitor treatment

  • Ya Ting Chen
  • , John Wen Cheng Chang
  • , Hui Ping Liu
  • , Tsung Fu Yu
  • , Yu Ting Chiu
  • , Jia Juan Hsieh
  • , Ying Tsong Chen
  • , Yi Rong Chen
  • , Hong Dar Isaac Wu
  • , Shiu Feng Huang*
  • *Corresponding author for this work
  • National Health Research Institutes Taiwan
  • Chang Gung Memorial Hospital
  • BenQ Medical Center
  • National Chung Hsing University
  • Tzu Chi University

Research output: Contribution to journalJournal Article peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical implications of high MET gene dosage in non-small cell lung cancer patients without previous tyrosine kinase inhibitor treatment'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience